Skip to main content
. 2020 Nov 9;48(21):12169–12187. doi: 10.1093/nar/gkaa963

Table 1.

Yeast strains used in this study

No. Name Genotype Source
1991 wt MATa, ade2–1 his3–11 leu2–3 trp1–1 ura3–1 can1–100, UBR1::GAL1–10-Ubiquitin-M-LacI fragment-Myc-UBR1 (HIS3), leu2–3::pCM244 (CMVp-tetR’-SSN6, LEU2) x3 S. Tanaka, J. F. Diffley, Nature Cell Biology. 4, 198–207 (2002).
1993 tof1Δ 1991 + TOF1::hphMX This study
1528 TOF1 1991 + TOF1::TOF1-codon-optimised-wildtype (NATNT2) This study
1549 tof1 627 1991 + TOF1::tof1-codon-optimised-627–1238Δ (NATNT2) This study
1596 tof1 762 1991 + TOF1::tof1-codon-optimised-762–1238Δ (NATNT2) This study
1589 tof1 830 1991 + TOF1::tof1-codon-optimised-830–1238Δ (NATNT2) This study
1546 tof1 997 1991 + TOF1::tof1-codon-optimised-997–1238Δ (NATNT2) This study
1537 tof1 1182 1991 + TOF1::tof1-codon-optimised-1182–1238Δ (NATNT2) This study
2188 TOF1 wt TAP 1991 + endogenous TOF1 tagged with TAP (KanMX) This study
2182 TOF1 TAP 1991 + TOF1::tof1-codon-optimised-wildtype-TAP (KanMX) This study
2183 tof1 627 TAP 1991 + TOF1::tof1-codon-optimised-627–1238Δ-TAP (KanMX) This study
2184 tof1 762 TAP 1991 + TOF1::tof1-codon-optimised-762–1238Δ-TAP (KanMX) This study
2185 tof1 830 TAP 1991 + TOF1::tof1-codon-optimised-830–1238Δ-TAP (KanMX) This study
2186 tof1 997 TAP 1991 + TOF1::tof1-codon-optimised-997–1238Δ-TAP (KanMX) This study
2187 tof1 1182 TAP 1991 + TOF1::tof1-codon-optimised-1182–1238Δ-TAP (KanMX) This study
2288 TOF1 wt mrc1–3FLAG 1528 + Mrc1–3FLAG (NATNT2) This study
2191 TOF1 wt-TAP mrc1–3FLAG 2182 + Mrc1–3FLAG (NATNT2) This study
2192 tof1 627-TAP mrc1–3FLAG 2183 + Mrc1–3FLAG (NATNT2) This study
2194 tof1 762-TAP mrc1–3FLAG 2184 + Mrc1–3FLAG (NATNT2) This study
2195 tof1 830-TAP mrc1–3FLAG 2185 + Mrc1–3FLAG (NATNT2) This study
2196 tof1 997-TAP mrc1–3FLAG 2186 + Mrc1–3FLAG (NATNT2) This study
2197 tof1 1182-TAP mrc1–3FLAG 2187 + Mrc1–3FLAG (NATNT2) This study
2465 GAL-HA-TOF1 wt 1991 + TOF1:: GAL-S-HA-TOF1-codon-optimised-wt (TRP) This study
2466 GAL-HA-tof1 627 1991 + TOF1:: GAL-S-HA-TOF1-codon-optimised-627–1238Δ (TRP) This study
2467 GAL-HA-tof1 997 1991 + TOF1:: GAL-S-HA-TOF1-codon-optimised-997–1238Δ (TRP) This study
2468 GAL-HA-tof1 1182 1991 + TOF1:: GAL-S-HA-TOF1-codon-optimised-1182–1238Δ (TRP) This study
2414 wt TOF1 (diploid) MAT a/alpha (diploid) homozygous: ade2–1 his3–11 leu2–3 trp1–1 ura3–1 can1–100, UBR1::GAL1–10-Ubiquitin-M-LacI fragment-Myc-UBR1 (HIS3), leu2–3::pCM244 (CMVp-tetR’-SSN6, LEU2) x3,heterozygousTOF1::tof1-codon-optimised-wildtype (NATNT2) This study
2420 tof1 627 TAP top1-MYC (diploid) MAT a/alpha (diploid) heterozygous: ade2–1 his3–11 leu2–3 trp1–1 ura3–1 can1–100, UBR1::GAL1–10-Ubiquitin-M-LacI fragment-Myc-UBR1 (HIS3), leu2–3::pCM244 (CMVp-tetR’-SSN6, LEU2) x3 TOF1::tof1-codon-optimised-627–1238Δ-TAP (KanMX) Top1–9MYC (hphMX) This study
2463 tof1 997 TAP top1-myc (diploid) MAT a/alpha (diploid) homozygous: ade2–1 his3–11 leu2–3 trp1–1 ura3–1 can1–100, UBR1::GAL1–10-Ubiquitin-M-LacI fragment-Myc-UBR1 (HIS3), leu2–3::pCM244 (CMVp-tetR’-SSN6, LEU2) x3, heterozygous TOF1::tof1-codon-optimised-997–1238Δ-TAP (KanMX) Top1–9MYC (hphMX) This study
2416 tof1 1182 TAP top1-myc (diploid) MAT a/alpha (diploid) homozygous: ade2–1 his3–11 leu2–3 trp1–1 ura3–1 can1–100, UBR1::GAL1–10-Ubiquitin-M-LacI fragment-Myc-UBR1 (HIS3), leu2–3::pCM244 (CMVp-tetR’-SSN6, LEU2) x3, heterozygousTOF1::tof1-codon-optimised-1182–1238Δ-TAP (KanMX) Top1–9MYC (hphMX) This study
1988 csm3Δ 1991 + CSM3:: NATNT2 This study
684 tof1Δ rad9Δ 1993 + rad9::NATNT2 This study
2405 csm3Δ rad9Δ 1988 + rad9::KanMX This study
1718 TOF1 wt rad9Δ 1528 + rad9::KanMX This study
1719 tof1 627 rad9Δ 1549 + rad9::KanMX This study
1777 tof1 762 rad9Δ 1596 + rad9::KanMX This study
1767 tof1 830 rad9Δ 1589 + rad9::KanMX This study
1722 tof1 997 rad9Δ 1546 + rad9::KanMX This study
1769 tof1 1182 rad9Δ 1537 + rad9::KanMX This study
1762 TOF1 wt top2–4 pRS316 1528 + top2–4,pRS316 (URA) This study
1610 tof1 627 top2–4 pRS316 1549 + top2–4,pRS316 (URA) This study
2290 tof1 762 top2–4 pRS316 1596 + top2–4,pRS316 (URA) This study
1717 tof1 830 top2–4 pRS316 1589 + top2–4,pRS316 (URA) This study
1763 tof1 997 top2–4 pRS316 1546 + top2–4,pRS316 (URA) This study
1611 tof1 1182 top2–4 pRS316 1537 + top2–4,pRS316 (URA) This study
1731 wt pRS426-RFB 1991 + pRS426–1xRFB (URA) This study
1730 tof1Δ pRS426-RFB 1993 + pRS426–1xRFB (URA) This study
1732 TOF1 wt pRS426-RFB 1528 + pRS426–1xRFB (URA) This study
1739 tof1 627 pRS426-RFB 1549 + pRS426–1xRFB (URA) This study
2333 tof1 762 pRS426-RFB 1596 + pRS426–1xRFB (URA) This study
1740 tof1 830 pRS426-RFB 1589 + pRS426–1xRFB (URA) This study
1733 tof1 997 pRS426-RFB 1546 + pRS426–1xRFB (URA) This study
1741 tof1 1182 pRS426-RFB 1537 + pRS426–1xRFB (URA) This study